M1319 – Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1319
- Long description
- Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
- Short description
- Pts csp doc contact
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2024
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code M1319?
M1319 is a HCPCS Level II code for patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening.
Does Medicare cover M1319?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1311 – Anaphylaxis due to the vaccine on or before the date of the encounter
- M1312 – Patient not screened for tobacco use
- M1313 – Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
- M1314 – Bmi not documented and no reason is given
- M1315 – Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified
- M1316 – Current tobacco non-user
- M1317 – Patients who are counseled on connection with a csp and explicitly opt out
- M1318 – Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
- M1320 – Patients who screened positive for at least 1 of the 5 hrsns
- M1321 – Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
- M1322 – Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
- M1323 – Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
- M1324 – Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
- M1325 – Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
- M1326 – Patients with a diagnosis of hypotony
- M1327 – Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.